InvestorsHub Logo
Followers 2
Posts 651
Boards Moderated 0
Alias Born 02/19/2018

Re: IrinaNewInTown post# 24947

Saturday, 09/08/2018 10:08:32 AM

Saturday, September 08, 2018 10:08:32 AM

Post# of 83212
And ultimately here is why cvsi will prevail.
This information is getting out and cbd sales are exploding. It’s fantastic for all cbd stocks.

ATHM: Is the cannabinoid segment of supplement industry a challenging marketplace right now?

Germano: I don’t think so, and I’ll tell you why. For the past 5 years I have been involved in the hemp and phytocannabinoid space, and I am dedicating the rest of my life to bringing ingredients that nourish and support the body’s endocannabinoid system to the marketplace. We are in the midst of the perfect storm. One, the botanical travesty of how hemp—not marijuana—has been treated, or I should say, mistreated. And two, the medical travesty of how the endocannanbinoid system in the body has been ignored since it’s discovery in the 1990’s. It is time to dismantle the stigma that hampered research and education as the endocannanbinoid system needs to be taught from high school through graduate school or practitioner school.

In order to understand CBD, phytocannabinoids, and hemp and their usefulness to the body, one must truly understand the endocannanbinoid system. Here we have a physiological system that controls or influences all others. You cannot be healthy unless cannabinoid receptors in the body that are found everywhere, on every organ are being fed the cannabinoids. As I mentioned, we produce cannabinoids ourselves, and if we do not produce enough, endocannabinoid deficiency states are associated with migraines, fibromyalgia, irritable bowel syndrome, and inflammatory and neurological conditions.

~ Dr. Carl Germano